Logomix Partners with UTokyo IPC for Strategic Funding Boost
Deal News | Jul 30, 2025 | UTokyo Innovation Platform Co
UTokyo Innovation Platform Co., Ltd. (UTokyo IPC) has announced a 100 million yen follow-on investment in Logomix Inc., a startup focused on genome construction technologies. This funding, made through AOI 1 Fund, was in collaboration with multiple co-investors. Logomix, founded in 2019, aims to advance its Geno-Writing platform for developing off-the-shelf cell therapies. The company benefits from newly appointed Scientific Advisors and plans to expand its high-performance cell therapies in the U.S. market. Logomix's commitment to synthetic biology and bioengineering is backed by UTokyo IPC, which supports talent recruitment and R&D efforts to enhance the company's market reach.
Sectors
- Biotechnology
- Venture Capital
Geography
- Japan – Both UTokyo IPC and Logomix are headquartered in Tokyo, Japan, highlighting the primary geographical focus of the activities discussed in the article.
- United States – Logomix's strategic goals include expanding its cell therapy products in the U.S. market, indicating a geographical focus on the United States.
Industry
- Biotechnology – The article revolves around Logomix, a company that specializes in biotechnology, particularly in genome engineering and cell therapy.
- Venture Capital – UTokyo IPC's investment is part of a venture capital initiative aimed at supporting academic startups and fostering innovative ventures.
Financials
- 100 million yen – The amount invested by UTokyo IPC in Logomix as part of the follow-on investment.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Logomix Inc. | Target Company | Company | A biotechnology company focused on genome construction technologies, founded in 2019 and originating from Tokyo Institute of Science. |
| UTokyo Innovation Platform Co., Ltd. | Investor | Company | A venture capital firm owned by the University of Tokyo, supporting academic startups and managing multiple investment vehicles. |
| Angel Bridge Inc. | Co-Investor | Company | One of the co-investors involved in the recent funding round for Logomix. |
| JAFCO Group Co., Ltd. | Co-Investor | Company | A leading venture capital company partaking in the Logomix investment round. |
| Sand Hill Angels | Co-Investor | Company | An angel investment company participating in the co-investment with Logomix. |
| Globis Capital Partners | Co-Investor | Company | A venture capital firm contributing to Logomix's funding round. |
| Itochu Technology Ventures Inc. | Co-Investor | Company | A technology-focused venture firm participating as a co-investor. |
| Yasunori Aizawa | Co-CEO | Person | Co-CEO of Logomix, actively involved in the company's strategic direction. |
| Taiki Ishikura | Co-CEO | Person | Co-CEO of Logomix, responsible for company leadership alongside Yasunori Aizawa. |